Canada covid-19 vaccine J&J Canada

Health Canada adds autoimmune disorder warning to AstraZeneca, J&J COVID-19 vaccines

Reading now: 481
globalnews.ca

Health Canada is updating the labels for the AstraZeneca and Johnson & Johnson COVID-19 vaccines to add immune thrombocytopenia (ITP), an autoimmune condition, as a potential side effect.In a statement on Tuesday, the agency said very rare cases of ITP have been reported internationally after receiving the Vaxzevria (AstraZeneca) and Janssen (J&J) COVID-19 vaccines.ITP is a disorder that can cause easy or excessive bruising and bleeding, which results from unusually low blood platelet levels.

Why rare blood clots could be a side effect of AstraZeneca COVID-19 vaccine Such cases typically occur within 28 days after vaccination, the agency said.

Read more on globalnews.ca
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA